Alfresa Holdings Corporation Stock
Stocks
2784
JP3126340003
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Japan Exchange
02:30:00 2026-10-23 am EDT
|
5-day change | 1st Jan Change | ||
| 2,406.50 JPY | +1.45% |
|
+3.26% | -1.01% |
| Oct. 05 | Healios Completes First 144 Million Yen Culture Supernatant Shipment to JENECEL | MT |
| Jun. 30 | Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation | CI |
| Market Cap | 422B 2.69B 2.4B 2.22B 2.01B 3.77B 256B 3.83B 26.72B 10.58B 134B 10.1B 9.89B | P/E 2027 * |
18.2x | P/E 2028 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 422B 2.69B 2.4B 2.22B 2.01B 3.77B 256B 3.83B 26.72B 10.58B 134B 10.1B 9.89B | EV / Sales 2027 * |
0.13x | EV / Sales 2028 * | 0.13x |
| Free-Float |
88.98% | Yield 2027 * |
2.95% | Yield 2028 * | 3.31% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 2784 | Delayed | |
OTC Markets
| ARHCF | Delayed |
| 1 day | +1.45% | ||
| 1 week | +3.26% | ||
| Current month | +5.73% | ||
| 1 month | +2.27% | ||
| 3 months | +3.84% | ||
| 6 months | +1.28% | ||
| Current year | -1.01% |
| 1 week | 2,331 |  | 2,439 |
| 1 month | 2,210 | | 2,439 |
| Current year | 2,106.5 | | 2,685.5 |
| 1 year | 2,106.5 | | 2,685.5 |
| 3 years | 1,897 | | 2,685.5 |
| 5 years | 1,505 | | 2,685.5 |
| 10 years | 1,505 | | 3,350 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ryuji Arakawa
CEO | Chief Executive Officer | 63 | - |
Watase Maiko
ADM | Chief Administrative Officer | - | - |
Toshiki Tanaka
CTO | Chief Tech/Sci/R&D Officer | 63 | 2022-06-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryuji Arakawa
BRD | Director/Board Member | 63 | 2007-05-31 |
Yuji Ueda
BRD | Director/Board Member | 65 | 2025-06-24 |
Yusuke Fukujin
BRD | Director/Board Member | 50 | 2020-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.45% | +3.26% | +10.16% | +0.94% | 2.69B | |
| +1.16% | -1.13% | -17.92% | +8.27% | 179B | |
| +0.02% | +4.24% | -19.82% | +16.53% | 118B | |
| -1.22% | +0.70% | +1.27% | +31.80% | 117B | |
| +2.29% | +17.36% | -41.94% | +9.49% | 93.26B | |
| -2.21% | -2.91% | +0.74% | +75.30% | 63.16B | |
| -1.06% | +1.75% | +13.50% | +80.00% | 55.68B | |
| -0.75% | +3.73% | +6.64% | -22.28% | 54.18B | |
| -1.13% | +0.00% | -12.25% | +31.02% | 44.15B | |
| +0.17% | +5.85% | -4.92% | -10.64% | 33.95B | |
| Average | -0.13% | +3.57% | -6.45% | +22.04% | 76.11B | |
| Weighted average by Cap. | +0.00% | +3.09% | -11.61% | +22.39% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 3,194B 20.37B 18.19B 16.8B 15.23B 28.49B 1,934B 28.96B 202B 80.05B 1,013B 76.44B 74.81B | 3,289B 20.97B 18.73B 17.3B 15.68B 29.33B 1,991B 29.82B 208B 82.43B 1,043B 78.71B 77.04B |
| Net income | 23.41B 149M 133M 123M 112M 209M 14.17B 212M 1.48B 587M 7.43B 560M 548M | 27.15B 173M 155M 143M 129M 242M 16.44B 246M 1.72B 680M 8.61B 650M 636M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | ¥2,406.50 | +1.45% | 497,700 |
| 26-10-22 | ¥2,372.00 | +0.89% | 471,100 |
| 26-10-21 | ¥2,351.00 | +0.13% | 457,000 |
| 26-10-20 | ¥2,348.00 | +0.26% | 233,800 |
| 26-10-19 | ¥2,342.00 | +0.49% | 423,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2784 Stock
Select your edition
All financial news and data tailored to specific country editions
